Obesity: Current and potential pharmacotherapeutics and targets

V Narayanaswami, LP Dwoskin - Pharmacology & therapeutics, 2017 - Elsevier
Obesity is a global epidemic that contributes to a number of health complications including
cardiovascular disease, type 2 diabetes, cancer and neuropsychiatric disorders …

The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations

DE Berryman, CAM Glad, EO List… - Nature Reviews …, 2013 - nature.com
Obesity has become one of the most common medical problems in developed countries,
and this disorder is associated with high incidences of hypertension, dyslipidaemia …

Obesity and cardiovascular risk: systematic intervention is the key for prevention

F Perone, A Pingitore, E Conte, G Halasz, M Ambrosetti… - Healthcare, 2023 - mdpi.com
Obesity is a serious public health issue and associated with an increased risk of
cardiovascular disease events and mortality. The risk of cardiovascular complications is …

Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging

Z Gong, E Tas, S Yakar, R Muzumdar - Molecular and cellular …, 2017 - Elsevier
Aging is associated with dysregulation of glucose and lipid metabolism. Various factors that
contribute to the dysregulation include both modifiable (eg obesity, insulin resistance) and …

Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and …

EO List, DE Berryman, K Funk, A Jara, B Kelder… - …, 2014 - academic.oup.com
GH is an important regulator of body growth and composition as well as numerous other
metabolic processes. In particular, liver plays a key role in the GH/IGF-I axis, because the …

Towards understanding the direct and indirect actions of growth hormone in controlling hepatocyte carbohydrate and lipid metabolism

MC Vázquez-Borrego, M del Rio-Moreno, RD Kineman - Cells, 2021 - mdpi.com
Growth hormone (GH) is critical for achieving normal structural growth. In addition, GH plays
an important role in regulating metabolic function. GH acts through its GH receptor (GHR) to …

The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice

EO List, DE Berryman, K Funk, ES Gosney… - Molecular …, 2013 - academic.oup.com
GH receptor (GHR) gene-disrupted mice (GHR−/−) have provided countless discoveries as
to the numerous actions of GH. Many of these discoveries highlight the importance of GH in …

The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease

LE Dichtel, KE Corey, J Misdraji… - Clinical and …, 2017 - journals.lww.com
OBJECTIVES: The mechanisms responsible for the development of nonalcoholic fatty liver
disease (NAFLD) and progression to nonalcoholic steatohepatitis (NASH) are incompletely …

Growth hormone control of hepatic lipid metabolism

Z Liu, J Cordoba-Chacon, RD Kineman… - Diabetes, 2016 - Am Diabetes Assoc
In humans, low levels of growth hormone (GH) and its mediator, IGF-1, associate with
hepatic lipid accumulation. In mice, congenital liver-specific ablation of the GH receptor …

Growth hormone improves adipose tissue browning and muscle wasting in mice with chronic kidney disease-associated cachexia

RH Mak, S Gunta, EA Oliveira, WW Cheung - International Journal of …, 2022 - mdpi.com
Cachexia associated with chronic kidney disease (CKD) has been linked to GH resistance.
In CKD, GH treatment enhances muscular performance. We investigated the impact of GH …